Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drgs and Industrie Limi...more...
Disclosure under regulation 29(2) of SEBI(SAST)Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drugs and Indus...more...
Disclosure under regulation 29(2) of SEBI (SAST) Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drugs and Industries L...more...
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drugs and Indu...more...
The company reported standalone net profit of Rs 0.16 crore for the quarter ended December 31 2025 as compared to Rs 0.24 crore in the same period la...more...
Unaudited Financial Results for the quarter ended 31st December 2025 along with Limited review report issued by the statutory auditors of the Companymore...
Board of Directors of Ishita Drugs and Industries Limited at its meeting held today i.e. Saturday 07th February 2026 have\r\n1. Approved the Unaudite...more...
Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter ali...more...
As of December 2025 50.04% is owned by Indian Promoters and 49.96% by Public. Top five Promoters holding highest number of shares of Ishita Drugs & I...more...
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st December 2025 as attached.more...
Change in Address of our RTA i.e. Bigshare Services Private Limited (Ahmedabad Branch)more...
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Mr. Jagdish Agrawal Promoter (M.D.)more...
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Jagdish Agrawal Promoter (M.D.)more...
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drugs and Industries Li...more...
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Ishita Pharmaceuticlas related party of Ishita Drugs and Indu...more...
Disclosure under Regulation 29(2) of SEBI(SAST) Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drugs and Industries Li...more...
Disclosure under regulation 29(2) of SEBI(SAST) Regulations 2011 received from Ishita Pharmaceuticals related party of Ishita Drugs & Industries Ltd.more...
BOARD MEETINGS Company Name : Guj. Intrux Date : 19-03-2026